Resistant Hypertension Clinical Trials
3 recruiting trials for Resistant Hypertension. Eligibility criteria explained in plain English.
TrialFinderData lists 3 Resistant Hypertension clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Mohamed Mohamed Ali Morgan (1), Universidade do Porto (1), First Affiliated Hospital of Chengdu Medical College (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Isometric Exercise (behavioral, 2 trials), followed by Transcutaneous Electrical Nerve Stimulation, Aerobic, Dynamic Resistance, stretch and Breathing Exercises and Lifestyle Modification Advices.
Track Resistant Hypertension trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Effect of Electrical Stimulation and Exercise on Blood Flow in Patients With Resistant High Blood Pressure
The goal of this clinical trial is to learn if the combination between transcutaneous electrical nerve stimulation (TENS) and isometric exercise (IE) can improve blood pressure in...
Evaluation of Two Isometric Exercises in the Reduction of the Blood Pressure in People With Resistant Hypertension
Hypertension remains the main preventable cause of cardiovascular disease (CVD) and all-cause mortality, both in Europe and globally. Resistant hypertension, a severe phenotype of...
Comparison of Catecholamine Concentrations in Venous Blood During Selective Adrenal Artery Embolization
To explore the relationship between perioperative blood pressure and catecholamine concentrations in adrenal venous blood and peripheral venous blood in hypertensive patients with...
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Resistant Hypertension, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Resistant Hypertension, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Resistant Hypertension, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.